The Recognition and Assessment of Cardiovascular Risk in People with Rheumatoid Arthritis in Primary Care: A Questionnaire‐Based Study of General Practitioners

Bell, Carolyn L.; Rowe, I. F.

doi:10.1002/msc.196

Cited by 44 publications

(45 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This assumption is problematic, however, because many primary care physicians are not aware of the increased CV risk in SLE and IA patients and also how to treat them [30]. The lack of CV risk assessment is pervasive as it was evident in two distinct rheumatology populations at this site-the SLE and IA patients.…”

Section: Discussionmentioning

confidence: 99%

Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center

2011

View full text Add to dashboard Cite

The purpose of this study is to evaluate cardiovascular risk assessment at a Canadian rheumatology center and describe the cardiovascular risk of inflammatory arthritis (IA) and systemic lupus erythematosus (SLE) patients using the Framingham risk score. A retrospective chart review of 504 patients attending nine rheumatology practices at the University of Alberta Hospital was performed. A pre-specified case report form detailed patient demographics, cardiac risk factors, variables for the Framingham 2008 score, disease activity, and medication use. In this group of 504 patients, 64 (12.7%) had SLE (male (M) to female (F) ratio=60:4) and 440 (87.3%) had an IA (M to F ratio=117:323). Of the SLE patients, 31 (48.4%) met four or more American College of Rheumatology (ACR) criteria, 33 (51.6%) had less than four ACR criteria. Of the IA patients, 156 (35.5%) were CCP positive and 257 (58.4%) were RF positive. Utilizing the chart data, retrospective Framingham risk scores were calculable for one (1.6%) SLE patient and three (0.68%) IA patients. The most common cardiac risk factors not documented in the medical records of both the SLE and IA patients included: (1) positive family history of MI, (2) diabetes, and (3) lipid status. The blood pressure was more frequently documented in the SLE patients (93.8%) compared to the IA patients (56.1%). While traditional cardiac risk factors only partially contribute to the increased cardiovascular risk in these patients, cardiovascular risk assessment was suboptimally performed amongst a large group of rheumatologists. A dedicated cardiovascular risk reduction clinic for inflammatory rheumatic diseases has been established at this site to fulfill this need and evaluate treatment strategies.

show abstract

Section: Discussionmentioning

confidence: 99%

Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center

2011

View full text Add to dashboard Cite

show abstract

“…Clinicians should be able to identify those patients at highest risk, to adapt their management accordingly. Unfortunately, cardiovascular risk in patients with RA is still underestimated in clinical practice, 114 and despite improvements in the understanding of the risk and the recommendations given by the European League Against Rheumatism (EULAR) Task Force, the management of cardiovascular risk remains unsatisfactory. 63,115 In the past 12 years, several algorithms have been developed to aid the prediction of risk for cardiovascular disease, such as the Framingham Risk Score, 116 the Reynolds Risk Score, 117,118 QRISK®2 (EMIS and the University of Nottingham, UK) 119 and SCORE.…”

Section: Risk-prediction Modelsmentioning

confidence: 99%

Cardiovascular comorbidity in rheumatic diseases

2015

View full text Add to dashboard Cite

Patients with rheumatoid arthritis (RA) and other inflammatory joint diseases (IJDs) have an increased risk of premature death compared with the general population, mainly because of the risk of cardiovascular disease, which is similar in patients with RA and in those with diabetes mellitus. Pathogenic mechanisms and clinical expression of cardiovascular comorbidities vary greatly between different rheumatic diseases, but atherosclerosis seems to be associated with all IJDs. Traditional risk factors such as age, gender, dyslipidaemia, hypertension, smoking, obesity and diabetes mellitus, together with inflammation, are the main contributors to the increased cardiovascular risk in patients with IJDs. Although cardiovascular risk assessment should be part of routine care in such patients, no disease-specific models are currently available for this purpose. The main pillars of cardiovascular risk reduction are pharmacological and nonpharmacological management of cardiovascular risk factors, as well as tight control of disease activity.

show abstract

“…Patients with high disease activity do not often consult healthcare personnel other than their rheumatologist34 and hence this reflects the low use of statins. Furthermore, the pleiotropic effect of statins, through anti-inflammation, may decrease disease activity and further reduce the need of DMARDs 28.…”

Section: Discussionmentioning

confidence: 99%

Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention

et al. 2014

View full text Add to dashboard Cite

show abstract

The Recognition and Assessment of Cardiovascular Risk in People with Rheumatoid Arthritis in Primary Care: A Questionnaire‐Based Study of General Practitioners

Cited by 44 publications

References 13 publications

Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center

Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center

Cardiovascular comorbidity in rheumatic diseases

Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention

Contact Info

Product

Resources

About